Eric Dyer Email & Phone Number

Secaucus, Nj, Us

Direct all preauthorization and billing-related activities for Quest’s Advanced Diagnostics Portfolio• Built department of approximately 100 direct and indirect reports• Established Quest’s reimbursement and supporting services policies for genomic portfolio• Expanded team by more than 50% in 12 month period• Increased favorable billing response rates by over 60% for key product offerings• Developed innovative, patient-facing preauthorization and out of pocket estimating process• Led initiative for comprehensive overhaul of exiting IT infrastructure supporting preauthorization team

Secaucus, Nj, Us

P&L responsibility for genetic testing programs in Women’s Health and Oncology Franchises• Defined and led operational changes resulting in 66% reduction in turnaround time and 50% reduction in cancellation rate• Successfully championed significant changes to billing policy, establishing a more competitive market position for Quest’s hereditary cancer portfolio• Named as leader of organization-wide genomics positioning project• Led efforts to define sales force targets and messaging, focusing on clients with highest potential for Quest• Launched four high-profile genetic test offerings in prenatal care and oncology• Launched 155-mutation NGS cystic fibrosis panel• Refined product positioning, collateral, and sales force training on more focused, clinically-relevant messaging

Founded genetic testing services company providing private-label access to EU-based hereditary cancer testing:¬¬¬¬• Targeting the underserved institutionally-based genetic counseling segment• Conducted thorough market research/proof of concept within academic genetic counseling community • Led Ethigen and partner laboratory through international CAP and CLIA accreditation processes• Successfully launched 19-gene hereditary cancer panel to US market in 2013

Salt Lake City, Utah, Us

Head of marketing for diagnostics organization dedicated to autism and developmental delay: • Instrumental role in fundraising and investor relations activities• Developed and executed parent/consumer awareness campaign • Executed multiple product line and digital platform launches in support of consumer outreach program• Exceeded pro-forma unit projections through highly-focused targeting and messaging strategy• Created consistent brand concept and segment-leading suite of physician and parental tools

Salt Lake City, Utah, Us

Leadership over portfolio of diagnostic tests for inherited sources of cancer risk: • Led COLARIS® franchise to 400% growth through effective strategic planning and leadership• Established Myriad’s business planning process for all products• Formalized organizational communication through establishment of cross-functional teams for all products• Created data reporting suite for all products• Simplified test ordering process for all products, reducing turnaround time by over 100%• Led clinical trials and publication efforts in support of better testing criteria for Lynch syndrome• Created award-winning Raise the Red Flag Campaign to bring greater awareness to hereditary cancer

Leadership over long-terms strategy for industry-leading hospital coding product• Launch first Windows-based version of company hospital coding product, previously stalled in development• Collaborated with developers, other stakeholders to identify next-generation coding solutions• Established roadmap to auto-coding, computer assisted hospital coding concepts

Us

P&L responsibility for antihypertensive products group:• Repositioned DynaCirc CR®, reversing 4-year trend of declining sales and share • Formulated integrated clinical trials, publication, and advocacy strategies to successfully reposition brand• Established competitive share of voice through restructuring of 1,000-person sales force alignment, compensation, and targeting structure• Expanded antihypertensive portfolio through acquisition, claims development, and launch strategies• Established deep KOL relationships among internationally renowned leaders in cardiovascular medicine• Created >100-member physician speaker bureau

Responsibility for company’s flagship brand, Remeron® (~$500MM 2001 annual sales):• Restored brand growth through extensive repositioning strategy• Allocated and managed $50MM annual promotional budget • Launched Remeron SolTab™ January 2001• Expanded into long term care segment for increase of $60MM in annual revenue• Managed clinical trial and publication strategy• Created and managed >400 member physician speaker bureau

Hospital-based sales of specialty products in psychiatry and anesthesia:• Ranked first nationally in market share growth, 1998• Promoted in September 1998 to Product Manager (relocated)

Bachelor Of Science (Bs), Marketing And Pre-Med Curriculum

Master Of Business Administration (Mba), Marketing/Marketing Management, General